If You Cut Supplement Facings in Q1, Swedencare's Q2 Says You May Have Been Early

You're planning your fall reset and the supplement aisle is still carrying the cuts you made earlier this year.

The signal you just got from Swedencare's Q2

Malmö-based Swedencare posted 4% year-over-year revenue growth in the second quarter ending June 30, hitting SEK 670 million. That's an acceleration from the 3% rise registered in the same period last year. The company's dental group, led by ProDen PlaqueOff, delivered a strong quarter across all segments, and its pharma products performed well in Europe and manufacturing.

The inflection matters because the company is showing momentum turning positive after a slower start to the year. If Swedencare's brands are moving again, the category may have found its floor faster than expected.

What this actually changes on your end

If you reduced supplement assortment earlier this year to protect margin, that decision was defensible then. The question now is whether the velocity assumption that drove it is still true.

Swedencare's CEO Håkan Lagerberg noted that consumers were cautious in May, "visibly affected by fuel prices and general economic uncertainty", but said the quarter finished in a more positive way. The company's gross margin expanded to 61% from 55.1% a year ago, driven partly by growth in Europe, where margins run higher.

That margin expansion tells you two things: the company is moving product at better economics, and the brands competing for the same shelf space may be feeling pressure to hold price or turn faster to keep their spots.

More reads like this, free, weekly. subscribe to PetRetailNews.

Here's the play if you stock supplements:

Pull your recent sell-through on the supplement brands you kept. If your remaining SKUs accelerated, the category likely did stabilize and your cuts worked. If they didn't, you may have left velocity on the table.

Watch whether competing supplement brands are pitching harder than usual. If Swedencare's momentum is real, brands that want shelf space will be pushing to win it. A rep offering better terms is a tell.

Don't add facings back just because one player posted a good quarter. Swedencare's North America segment, which represents 55% of the company's revenue, actually declined 3% in organic sales during Q2, which the company attributed to a delayed product launch with a significant new retailer and inventory reductions by a major veterinary distributor. The growth came from Europe (up 19% organically) and the production segment (up 25%). If your customer base doesn't mirror that geographic mix, the category signal may not apply to your market yet.

If you're a single-location store without dedicated category analytics, use your next order as a test. Bring back one SKU you trimmed earlier, ideally a dental or pharma product, since those were Swedencare's growth drivers, and give it a trial window. If it turns at the rate it did before you trimmed it, the category likely did recover. If it sits, you were right the first time.

The failure mode and what being wrong costs

The risk in acting too fast: you add back facings and the category momentum was actually Swedencare taking share rather than true category lift. You end up with more SKUs competing for the same customer spend, and your margin suffers.

The risk in waiting too long: if the category did stabilize and you're still running a reduced assortment, a competitor restocks the brands you trimmed and captures the customers who were looking for them. You lose the sale, and possibly the customer.

Swedencare expects high single-digit to low double-digit growth for the full year and said margins will improve in Q3, driven by better control of Amazon pricing (the company enrolled key SKUs in Amazon's Transparency Program to address sellers not following minimum advertised price policies) and new veterinary partnerships. If those plays work and the company posts another acceleration in Q3, the category signal gets stronger.

Our read: test before you commit, but don't ignore the turn

One quarter doesn't prove the category recovered. But an acceleration after a slower start to the year is the kind of inflection that usually means something changed, either the floor is in, or one player is taking share while others adjust.

The safest play is to treat your next order as a test rather than a reset. Bring back one or two SKUs you trimmed, watch what actually sells, and use that data to decide whether to expand facings. If Swedencare posts another strong quarter and your test SKUs turn, you'll have the evidence you need to adjust. If they don't, you're only carrying a couple extra SKUs for a trial period.

The question is whether the category actually turned, or whether Swedencare just got better at taking the share that was already there.

← Back to the Newsdesk